Ablation of SIRT3 causes coronary microvascular dysfunction and impairs cardiac recovery post myocardial ischemia

International Journal of Cardiology

Volumn 215, Issue , 2016, Pages 349-357

  He, Xiaochen ^a   Zeng, Heng ^a   Chen, Jian Xiong ^a  

^a UNIVERSITY OF MISSISSIPPI   (United States)

Author keywords

CFR; Myocardial ischemia; Pericyte; SIRT3

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; ANGIOPOIETIN 1; CASPASE 3; FRUCTOSE 2,6 BISPHOSPHATASE; SIRTUIN 3; VASCULOTROPIN; SIRT3 PROTEIN, MOUSE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD FLOW VELOCITY; CAPILLARY; CAPILLARY ENDOTHELIAL CELL; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CORONARY FLOW RESERVE; CORONARY MICROVASCULAR DYSFUNCTION; DISEASE EXACERBATION; DISEASE SEVERITY; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MICROANGIOPATHY; MOUSE; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; WILD TYPE; ANIMAL; CELL CULTURE; CONVALESCENCE; CORONARY BLOOD VESSEL; CYTOLOGY; DEFICIENCY; ENDOTHELIUM CELL; GENETICS; HUMAN; KNOCKOUT MOUSE; MICROVASCULATURE; PATHOPHYSIOLOGY;

ANIMALS; BLOOD FLOW VELOCITY; CELLS, CULTURED; CORONARY VESSELS; ENDOTHELIAL CELLS; HUMANS; MICE; MICE, KNOCKOUT; MICROVESSELS; MYOCARDIAL ISCHEMIA; RECOVERY OF FUNCTION; SIRTUIN 3;

EID: 84966269124     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2016.04.092     Document Type: Article

References (42)

1. D. Mozaffarian, E.J. Benjamin, A.S. Go, D.K. Arnett, M.J. Blaha, M. Cushman, and et al. Heart disease and stroke statistics - 2015 update: a report from the American Heart Association Circulation 131 4 Jan 27 2015 e29 322
2. E.G. Nabel, and E. Braunwald A tale of coronary artery disease and myocardial infarction N. Engl. J. Med. 366 1 Jan 5 2012 54 63
3. C.B. Fordyce, B.J. Gersh, G.W. Stone, and C.B. Granger Novel therapeutics in myocardial infarction: targeting microvascular dysfunction and reperfusion injury Trends Pharmacol. Sci. 36 9 Sep 2015 605 616
4. X. Hou, H. Zeng, X. He, and J.X. Chen Sirt3 is essential for apelin-induced angiogenesis in post-myocardial infarction of diabetes J. Cell. Mol. Med. 19 1 Jan 2015 53 61
5. G. Niccoli, G. Scalone, A. Lerman, and F. Crea Coronary microvascular obstruction in acute myocardial infarction Eur. Heart J. 12 Sep 2015
6. D.S. Menees, E.D. Peterson, Y. Wang, J.P. Curtis, J.C. Messenger, J.S. Rumsfeld, and et al. Door-to-balloon time and mortality among patients undergoing primary PCI N. Engl. J. Med. 369 10 Sep 5 2013 901 909
7. P.G. Camici, and F. Crea Coronary microvascular dysfunction N. Engl. J. Med. 356 8 Feb 22 2007 830 840
8. V.B. Pillai, N.R. Sundaresan, V. Jeevanandam, and M.P. Gupta Mitochondrial SIRT3 and heart disease Cardiovasc. Res. 88 2 Nov 1 2010 250 256
9. S. Winnik, J. Auwerx, D.A. Sinclair, and C.M. Matter Protective effects of sirtuins in cardiovascular diseases: from bench to bedside Eur. Heart J. 36 48 Dec 21 2015 3404 3412
10. F.P. Brouwers, R.A. de Boer, P. van der Harst, A.A. Voors, R.T. Gansevoort, S.J. Bakker, and et al. Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND Eur. Heart J. 34 19 May 2013 1424 1431
11. M. Tanno, A. Kuno, Y. Horio, and T. Miura Emerging beneficial roles of sirtuins in heart failure Basic Res. Cardiol. 107 4 Jul 2012 273
12. V. Guarani, and M. Potente SIRT1 - a metabolic sensor that controls blood vessel growth Curr. Opin. Pharmacol. 10 2 Apr 2010 139 145
13. R. Nogueiras, K.M. Habegger, N. Chaudhary, B. Finan, A.S. Banks, M.O. Dietrich, and et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism Physiol. Rev. 92 3 Jul 2012 1479 1514
14. A.H. Tseng, L.H. Wu, S.S. Shieh, and D.L. Wang SIRT3 interactions with FOXO3 acetylation, phosphorylation and ubiquitinylation mediate endothelial cell responses to hypoxia Biochem. J. 464 1 Nov 15 2014 157 168
15. S. Matsushima, and J. Sadoshima The role of sirtuins in cardiac disease Am. J. Physiol. Heart Circ. Physiol. 309 9 Nov 2015 H1375 H1389
16. N.R. Sundaresan, S.A. Samant, V.B. Pillai, S.B. Rajamohan, and M.P. Gupta SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70 Mol. Cell. Biol. 28 20 Oct 2008 6384 6401
17. I.R. Lanza, D.K. Short, K.R. Short, S. Raghavakaimal, R. Basu, M.J. Joyner, and et al. Endurance exercise as a countermeasure for aging Diabetes 57 11 Nov 2008 2933 2942
18. H. Zeng, X. He, X. Hou, L. Li, and J.X. Chen Apelin gene therapy increases myocardial vascular density and ameliorates diabetic cardiomyopathy via upregulation of sirtuin 3 Am. J. Physiol. Heart Circ. Physiol. 306 4 Feb 15 2014 H585 H597
19. J.X. Chen, and A. Stinnett Ang-1 gene therapy inhibits hypoxia-inducible factor-1alpha (HIF-1alpha)-prolyl-4-hydroxylase-2, stabilizes HIF-1alpha expression, and normalizes immature vasculature in db/db mice Diabetes 57 12 Dec 2008 3335 3343
20. L. Li, H. Zeng, and J.X. Chen Apelin-13 increases myocardial progenitor cells and improves repair postmyocardial infarction Am. J. Physiol. Heart Circ. Physiol. 303 5 Sep 1 2012 H605 H618
21. S. Gao, D. Ho, D.E. Vatner, and S.F. Vatner Echocardiography in mice Curr. Protoc. Mouse Biol. 1 Mar 1 2011 71 83
22. W.T. Chang, S. Fisch, M. Chen, Y. Qiu, S. Cheng, and R. Liao Ultrasound based assessment of coronary artery flow and coronary flow reserve using the pressure overload model in mice J. Vis. Exp. 98 2015 e52598
23. J. You, J. Wu, J. Ge, and Y. Zou Comparison between adenosine and isoflurane for assessing the coronary flow reserve in mouse models of left ventricular pressure and volume overload Am. J. Physiol. Heart Circ. Physiol. 303 10 Nov 15 2012 H1199 H1207
24. A. Pozzi, P.E. Moberg, L.A. Miles, S. Wagner, P. Soloway, and H.A. Gardner Elevated matrix metalloprotease and angiostatin levels in integrin alpha 1 knockout mice cause reduced tumor vascularization Proc. Natl. Acad. Sci. U. S. A. 97 5 Feb 29 2000 2202 2207
25. J.X. Chen, M.L. Lawrence, G. Cunningham, B.W. Christman, and B. Meyrick HSP90 and Akt modulate Ang-1-induced angiogenesis via NO in coronary artery endothelium J. Appl. Phycol. (1985) 96 2 Feb 2004 612 620
26. B.H. Ahn, H.S. Kim, S. Song, I.H. Lee, J. Liu, A. Vassilopoulos, and et al. A role for the mitochondrial deacetylase Sirt3 in regulating energy homeostasis Proc. Natl. Acad. Sci. U. S. A. 105 38 Sep 23 2008 14447 14452
27. M.D. Hirschey, T. Shimazu, E. Goetzman, E. Jing, B. Schwer, D.B. Lombard, and et al. SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation Nature 464 7285 Mar 4 2010 121 125
28. E. McDonnell, B.S. Peterson, H.M. Bomze, and M.D. Hirschey SIRT3 regulates progression and development of diseases of aging Trends Endocrinol. Metab. 26 9 Sep 2015 486 492
29. H.S. Kim, K. Patel, K. Muldoon-Jacobs, K.S. Bisht, N. Aykin-Burns, J.D. Pennington, and et al. SIRT3 is a mitochondria-localized tumor suppressor required for maintenance of mitochondrial integrity and metabolism during stress Cancer Cell 17 1 Jan 19 2010 41 52
30. T.P. van de Hoef, M. Echavarria-Pinto, M.A. van Lavieren, M. Meuwissen, P.W. Serruys, J.G. Tijssen, and et al. Diagnostic and prognostic implications of coronary flow capacity: a comprehensive cross-modality physiological concept in ischemic heart disease J. Am. Coll. Cardiol. Intv. 8 13 Nov 2015 1670 1680
31. T.M. Leucker, M. Bienengraeber, M. Muravyeva, I. Baotic, D. Weihrauch, A.K. Brzezinska, and et al. Endothelial-cardiomyocyte crosstalk enhances pharmacological cardioprotection J. Mol. Cell. Cardiol. 51 5 Nov 2011 803 811
32. Q.H. Tuo, H. Zeng, A. Stinnett, H. Yu, J.L. Aschner, D.F. Liao, and et al. Critical role of angiopoietins/Tie-2 in hyperglycemic exacerbation of myocardial infarction and impaired angiogenesis Am. J. Physiol. Heart Circ. Physiol. 294 6 Jun 2008 H2547 H2557
33. J. Goveia, P. Stapor, and P. Carmeliet Principles of targeting endothelial cell metabolism to treat angiogenesis and endothelial cell dysfunction in disease EMBO Mol. Med. 6 9 2014 Sep 1105 1120
34. B.K. De, M. Georgiadou, S. Schoors, A. Kuchnio, B.W. Wong, A.R. Cantelmo, and et al. Role of PFKFB3-driven glycolysis in vessel sprouting Cell 154 3 Aug 1 2013 651 663
35. G.A. Porter, W.R. Urciuoli, P.S. Brookes, and S.M. Nadtochiy SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts Am. J. Physiol. Heart Circ. Physiol. 306 12 Jun 15 2014 H1602 H1609
36. Y. Xu, X. An, X. Guo, T.G. Habtetsion, Y. Wang, X. Xu, and et al. Endothelial PFKFB3 plays a critical role in angiogenesis Arterioscler. Thromb. Vasc. Biol. 34 6 Jun 2014 1231 1239
37. M. Obach, A. Navarro-Sabate, J. Caro, X. Kong, J. Duran, M. Gomez, and et al. 6-phosphofructo-2-kinase (pfkfb3) gene promoter contains hypoxia-inducible factor-1 binding sites necessary for transactivation in response to hypoxia J. Biol. Chem. 279 51 2004 Dec 17 53562 53570
38. O. Minchenko, I. Opentanova, and J. Caro Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene family (PFKFB-1-4) expression in vivo FEBS Lett. 554 3 Nov 20 2003 264 270
39. H. Zeng, X. He, Q.H. Tuo, D.F. Liao, G.Q. Zhang, and J.X. Chen LPS causes pericyte loss and microvascular dysfunction via disruption of SIRT3/angiopoietins/Tie-2 and HIF-2a/Notch3 pathways Sci. Rep. 2016 (in press)
40. G. Niccoli, F. Burzotta, L. Galiuto, and F. Crea Myocardial no-reflow in humans J. Am. Coll. Cardiol. 54 4 Jul 21 2009 281 292
41. H. Ito No-reflow phenomenon and prognosis in patients with acute myocardial infarction Nat. Clin. Pract. Cardiovasc. Med. 3 9 Sep 2006 499 506
42. F.M. O'Farrell, and D. Attwell A role for pericytes in coronary no-reflow Nat. Rev. Cardiol. 11 7 Jul 2014 427 432